Forecasting – Patient-Based Forecasting-Pharma

Our client approached us to help it evaluate the potential of a small molecule therapeutic vs. an antibody therapeutic for the prevention of cytomegalovirus (CMV) infection in a number of special populations in 7 major markets.

Our Solution

GlobalData designed a study to:

• Map clinical pathways for prevention, diagnosis, and treatment
• Identify current trends and future unmet needs in key market segments/patient populations
• Develop an ideal therapeutic product profile including efficacy, safety, formulation, cost, and compliance
• Forecast the current and future market size, and the impact of market events
• 40 KOL interviews in the US, Japan, and EU
• Extensive quantitative and qualitative secondary research

Outcome

GlobalData delivered clear insights into unmet needs, product uptake scenarios based on clinical attributes, and a comprehensive patient model/forecast, complete with specialty segments and impacts of potential market events.